Volker Endris Selected Research

Combination Drug Therapy (Combination Chemotherapy)

1/2018

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Volker Endris Research Topics

Disease

56	Neoplasms (Cancer) 06/2023 - 10/2013
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 11/2015
8	Lung Neoplasms (Lung Cancer) 08/2021 - 11/2013
7	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 12/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 11/2021 - 03/2016
3	Carcinoma (Carcinomatosis) 09/2023 - 10/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 01/2017
3	Disease Progression 11/2021 - 12/2019
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2020 - 01/2018
3	Adenocarcinoma 12/2018 - 10/2013
2	Microsatellite Instability 01/2022 - 01/2017
2	Chromothripsis 01/2022 - 01/2017
2	Turcot syndrome 06/2021 - 01/2018
2	Pancreatic Cyst 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 12/2018 - 01/2017
2	Leukemia 01/2017 - 09/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 06/2016
2	Adenocarcinoma of Lung 01/2017 - 11/2013
2	Breast Neoplasms (Breast Cancer) 10/2016 - 10/2014
2	Intellectual Disability (Idiocy) 06/2010 - 09/2002
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2020
1	Schwannomatosis 01/2020
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2020
1	Neurilemmoma (Schwannoma) 01/2020
1	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2018
1	Pancreatitis 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Chronic Pancreatitis 01/2017
1	Triple Negative Breast Neoplasms 10/2016

Drug/Important Bio-Agent (IBA)

15	Formaldehyde (Formol)FDA Link 10/2020 - 11/2013
15	ParaffinIBA 10/2020 - 11/2013
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
11	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 06/2010
7	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2017
7	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2017
7	Tyrosine Kinase InhibitorsIBA 05/2021 - 01/2017
4	Anaplastic Lymphoma KinaseIBA 05/2021 - 01/2018
3	Cell-Free Nucleic AcidsIBA 12/2020 - 01/2018
3	CateninsIBA 11/2020 - 01/2019
3	Calcibiotic Root Canal SealerIBA 10/2020 - 12/2014
3	Phosphotransferases (Kinase)IBA 01/2020 - 03/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 11/2015
2	Codon (Codons)IBA 06/2021 - 07/2015
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2020
2	Circulating Tumor DNAIBA 01/2018 - 10/2017
2	olaparibIBA 01/2017 - 06/2016
2	taxaneIBA 01/2017 - 10/2016
2	PlatinumIBA 01/2017 - 06/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2023
1	A-Form DNA (A-DNA)IBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2021
1	NucleotidesIBA 12/2020
1	Cadherins (E-Cadherin)IBA 10/2020
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 10/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	AntigensIBA 01/2020
1	antigen CYFRA21.1IBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Blood Proteins (Serum Proteins)IBA 12/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019
1	Adenosine Monophosphate (AMP)IBA 09/2019
1	Mitochondrial DNA (mtDNA)IBA 12/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	VaccinesIBA 01/2018
1	ProteomeIBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Panitumumab (Vectibix)FDA Link 01/2018
1	osimertinibIBA 10/2017
1	AntioxidantsIBA 07/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Poly Adenosine Diphosphate RiboseIBA 01/2017
1	InterferonsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Core Binding Factors (Core-Binding Factor)IBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	AnthracyclinesIBA 10/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2016

Therapy/Procedure

27	Therapeutics 11/2021 - 11/2013
7	Drug Therapy (Chemotherapy) 01/2018 - 10/2013
6	Precision Medicine 07/2021 - 08/2015
3	Castration 01/2022 - 01/2017
3	Immunotherapy 01/2021 - 01/2018
3	Semiconductors 05/2015 - 11/2013
2	Radiotherapy 11/2021 - 01/2020
2	Neoadjuvant Therapy 10/2016 - 05/2016
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Chemoprevention 01/2018